Your contact

Dr. Petra Burgstaller

Co-Lead Venture Creation & MAxL

Christina Enke-Stolle

Co-Lead Venture Creation & MAxL

Presenting persuasively to investors

Turn your idea into a compelling story! Our Pitch Days take place twice a year and give selected teams the opportunity to present their investor pitch to investors. Training sessions and individual coaching sessions beforehand will help you win over investors and present your start-up project effectively.

Pitch Training

In our "Pitch Training" you will learn how to structure your short presentation in a meaningful way and how to present all important information for an investment decision in a compact and clearly understandable way. You will improve the quality of your presentation, receive feedback on your presentation style, and learn how to appear convincing and pitch professionally to investors.

Individual Consultation

Of course, you can also contact us at any time if you would like to receive feedback on the presentation of your start-up project. As a sparring partner, we help you to clearly define your business concept contentwise and make your investor pitch compelling.

„Communicating essential information in a targeted, convincing and concise manner is a huge challenge. Enhancing and practicing this skill in the workshop was very helpful.“
Dr. Hannelore Meyer
Technical University of Munich

More on the topic

06.07.2026
m4 award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteria
Munich-based m4 Award winner smartbax has successfully expanded its pre-Series A funding round to a total of 6.3 million euros. With the additional capital, the biotech company plans to…
m<sup>4</sup> award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteria
01.07.2026
Mallia secures €3 million financing to accelerate commercial expansion of the 8T3 Essentials Line
Mallia Innovations GmbH, the holding company strategically driving the development and commercialization of biopharmaceutical therapies targeting hair loss and wound healing as well as…
Mallia secures €3 million financing to accelerate commercial expansion of the 8T3 Essentials Line
25.06.2026
Roche's Dr. Anna Bauer-Mehren joins AI4Biotech Session – Navigating the AI Transition in Biotech and Life Sciences
The expert line-up for BioM's "AI4Biotech Session – Biotech AI Compass: Lead Your Organization Through the AI Transition" is complete: Dr. Anna Bauer-Mehren, a trained bioinformatician who…
Roche's Dr. Anna Bauer-Mehren joins AI4Biotech Session – Navigating the AI Transition in Biotech and Life Sciences